Beijing Hotgen Biotech Co., Ltd. (SHSE: 688068)
Health Care · Life Sciences Tools & Services · CN
CN¥84.54
-10.51% today · -48.6% 1Y
Beijing Hotgen Biotech Co., Ltd. (SHSE: 688068) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.11B and employs 946 people.
Over the last twelve months the share price has lost 48.6%, trading between 73.44 and 214.78.
Tweenvest scores Beijing Hotgen Biotech Co., Ltd. across four factors: quality 61/100, value 60/100, growth 0/100. Its strongest factor is quality.
688068 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.11B
- Revenue (TTM)
- $69.07M
- P/E
- —
- EPS
- -2.79
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- CN¥214.78
- 52-week low
- CN¥73.44
- Avg volume (3M)
- —
- Shares outstanding
- 88.17M
- Employees
- 946
- Next earnings
- —
About Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd. specializes in the complete process, from research and development to manufacturing and sales, of in-vitro diagnostic (IVD) solutions for medical and public safety purposes within the biomedical field. Their comprehensive range of products incorporates cutting-edge technologies like drug detection, CDC-compliant methods, up-conversion luminescence, colloidal gold, CLIA, sugar capture, microfluidics, and gene detection. These advanced diagnostic tools are designed to identify a broad spectrum of targets, including intestinal microorganisms, pathogens causing gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, various infectious diseases, Ebola virus antigens, biological warfare agents, other microorganisms, and mycotoxins. The company, founded in 2005, is headquartered in Beijing, China.
- ISIN
- CNE100003P82
- Founded
- 2005
- Listed since
- Sep 30, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Indegene LimitedNSEI: INDGN | $1.44B | Rs580.10 | -2.26% |
| Syngene International LimitedNSEI: SYNGENE | $1.43B | Rs347.40 | -3.85% |
| Novogene Co., Ltd.SHSE: 688315 | $1.31B | CN¥21.73 | +9.91% |
| Akums Drugs and Pharmaceuticals LimitedNSEI: AKUMS | $1.19B | Rs751.85 | -7.53% |
| Maravai LifeSciences Holdings, Inc.NasdaqGS: MRVI | $1.11B | $7.26 | -2.42% |
| Gerresheimer AGXTRA: GXI | $1.11B | €28.84 | +0.63% |
| Beijing Sun-Novo Pharmaceutical Research Co., Ltd.SHSE: 688621 | $1.09B | CN¥67.05 | -5.56% |
| PharmaResources (Shanghai) Co., Ltd.SZSE: 301230 | $974.39M | CN¥36.42 | -5.35% |
Figures last refreshed Oct 11, 2026.